Impact of Short-Acting Spinal Anesthetic on Discharge from Postanesthetic Care Unit: A Retrospective Analysis.

Can J Hosp Pharm

, BSc(Pharm), MSc, MHA, is the Regional Medication Use Management Coordinator with Lower Mainland Pharmacy Services, Vancouver, British Columbia.

Published: March 2025

Background: Chloroprocaine has recently regained accessibility as a short-acting local anesthetic in Canada. It offers an alternative to bupivacaine, the predominant spinal anesthetic used at Vancouver Coastal Health sites in Vancouver, British Columbia.

Objective: To compare the recovery profile of surgical patients who received either chloroprocaine or bupivacaine for spinal anesthesia.

Methods: This multicentre retrospective cohort study involved adult patients who received chloroprocaine or bupivacaine as spinal anesthetic for short-duration surgery. The primary outcome was the time from admission to the postanesthesia care unit (PACU) to discharge from the PACU. Time from PACU admission to discharge readiness was also assessed, along with the perioperative variables of type of operation performed, duration of surgery, dose of anesthetic, dose of intraoperative analgesic, and number of days from operation to hospital discharge.

Results: The study involved 145 patients aged 30 to 94 years: 72 who received chloroprocaine and 73 who received bupivacaine. For the primary outcome, there was a nonsignificant shorter time from PACU admission to discharge for the chloroprocaine cohort (mean difference 36 minutes, = 0.07). There was a significant difference favouring chloroprocaine over bupivacaine in the time from PACU admission to meeting PACU discharge criteria (mean difference 48 minutes, < 0.001). Chloroprocaine was associated with significantly shorter surgery duration (mean difference 5 minutes, = 0.026). Regression analysis showed a significant correlation between the anesthetic given and the time to meeting PACU discharge eligibility ( < 0.001).

Conclusion: Use of chloroprocaine was associated with earlier time to patients meeting PACU discharge criteria. These findings support the potential benefit of chloroprocaine over bupivacaine in terms of achieving earlier PACU discharge readiness, although this difference did not consistently translate into earlier actual PACU discharge.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11879361PMC
http://dx.doi.org/10.4212/cjhp.3618DOI Listing

Publication Analysis

Top Keywords

pacu discharge
24
chloroprocaine bupivacaine
16
spinal anesthetic
12
received chloroprocaine
12
time pacu
12
pacu admission
12
difference minutes
12
meeting pacu
12
pacu
10
discharge
9

Similar Publications

Impact of Short-Acting Spinal Anesthetic on Discharge from Postanesthetic Care Unit: A Retrospective Analysis.

Can J Hosp Pharm

March 2025

, BSc(Pharm), MSc, MHA, is the Regional Medication Use Management Coordinator with Lower Mainland Pharmacy Services, Vancouver, British Columbia.

Background: Chloroprocaine has recently regained accessibility as a short-acting local anesthetic in Canada. It offers an alternative to bupivacaine, the predominant spinal anesthetic used at Vancouver Coastal Health sites in Vancouver, British Columbia.

Objective: To compare the recovery profile of surgical patients who received either chloroprocaine or bupivacaine for spinal anesthesia.

View Article and Find Full Text PDF

Objective: Postoperative nausea and vomiting (PONV) is a frequent adverse event after bariatric surgery and is associated with patient dissatisfaction and increased health care burden. Aggressive multimodal antiemetic prophylaxis and the use of propofol infusion during anesthesia are associated with the reduction of PONV. In this study, we examined the use of rescue antiemetics following bariatric surgery performed with 3 different anesthetic strategies designed to reduce PONV: (1) primary volatile (VOL) anesthetic and propofol (PROP) infusion (VOL+PROP), (2) volatile anesthetic with propofol and dexmedetomidine (DEX) infusions (VOL+PROP+DEX), or (3) opioid-sparing total intravenous anesthesia (PROP+DEX).

View Article and Find Full Text PDF

Background: Laparoscopic appendectomy is a common emergency surgical procedure worldwide, known for its benefits of reduced pain, shorter hospital stays, and quicker recovery times. Although postoperative care typically involves observation on the surgical floor, advances in surgical techniques and perioperative care have introduced the potential for discharging patients directly from the post-anesthesia care unit (PACU). This study aims to evaluate the safety and cost-effectiveness of direct PACU discharge compared to traditional floor admission for patients undergoing uncomplicated laparoscopic appendectomy.

View Article and Find Full Text PDF

Background: Although the importance of transporter availability to the operating room and phase I postanesthesia care unit workflow has been known since Marcon et al Anesth & Analg 2003, no detailed data have been published about patient transport times. Nearly all facilities know the times of postanesthesia care unit (PACU) discharges, but transport time through when the transporter returns consumes porter resources.

Methods: Epic's Rover was implemented to track all PACU transports, 22,846 from July 2022 through April 2024.

View Article and Find Full Text PDF

Upon the induction of general anesthesia, a predictable sequence of physiological changes occurs within the respiratory and neuromuscular systems. The sequelae of these changes include an assortment of postoperative pulmonary complications (PPCs), including postoperative respiratory depression (PORD), that are observed during the immediate postoperative period and in the post-anesthesia care unit (PACU). These adverse events are anticipated, because several of the drugs that are used during surgery (e.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!